Tuesday, March 31, 2009

It's 1984 & 1 In Every 5 Are Incurably Mentally Ill ~ Repost

Soulful Sepulcher has:

You Reside In Pharmaceutical Dreams Of The Future

"Do you begin to see, then, what kind of world we are creating? It is the exact opposite of the stupid hedonistic Utopias that the old reformers imagined. A world of fear and treachery and torment, a world of trampling and being trampled upon, a world which will grow not less but more merciless as it refines itself. Progress in our world will be progress toward more pain."
~
"Never again will you be capable of ordinary human feeling. Everything will be dead inside you. Never again will you be capable of love, or friendship, or joy of living, or laughter, or curiosity, or courage, or integrity. You will be hollow. We shall squeeze you empty and then we shall fill you with ourselves."

1 in 5 Are Incurably 'Mentally Ill'

The Pharmaceutical Machinations and Vote Buying that rigged this 1 in 5 profiteering hustle in the 1st place are laid out in Allen Jones exposition of TMAP: the Texas Medication Algorithm Project.

See Allen Jones Full Whistle-Blower Report, pg.3.

"Newspaper columnist Charles T. Bowen, in an article "Quick Note; Silent Vote; No Gloat."

The Tampa Tribune, 21 April 1997, described how one former Texas legislator, Tom Robbins, was annoyed that his colleagues seemed to pass legislation that they had not even read, let alone understood. To prove a point he introduced a resolution to honor Albert de Salvo. The language of the resolution stated in part:

"This compassionate gentleman's dedication and devotion to his work has enabled the weak and the lonely throughout the nation to achieve and maintain a new degree of concern for their future. He has been officially recognized by the state of Massachusetts for his noted activities and unconventional techniques involving population control and applied psychology."

The Resolution passed with a unanimous vote.

Albert de Salvo was, of course, the Boston Strangler.

According to the National Institute on Money in State Politics, the pharmaceutical industry Contributed zero contributions to individual politicians in Texas in1994. During the 1998 Election year, pharmaceutical manufacturers made a total of 251 contributions totaling $152,000 to individual candidates for Texas state office. In 2002, the total was 419 individual contributions by drug makers totaling $384,735."


We should not be outraged that politicians can be bought, ..... that's a given. But we Should be outraged that they can be bought so cheaply, ...... because That is the reason Why, ..... 1 in Every 5 Americans are today being hunted, ..... by Ideates, ..... as dinner.

Sunday, March 29, 2009

Preemption: It's ALIVE, & Worming Into State Legislatures

Just because the US Supreme Court Slapped down the FDA's Delusions of Supremacy, Doesn't mean we've made it through Preemptocrat Pass yet.

Pharma's Preemption Medusa is worming its Snake heads through the State Legislatures: attempting to keep You and Your's out of Court, after Pharma's Chemicals Put You and Your's Into the Hospital or the Grave.

Pharmalittle has:

MICHIGAN HOUSE RESCINDS FDA PREEMPTION LAW .... AGAIN

As Justice In Michigan - who wrote the post - noted:
"(Indeed, writing for the majority in Levine, Justice Stevens wryly noted that the dissenting Justices had done a far more thorough job reviewing Phenergan's risks and benefits than the FDA ever did.)"
There's a lot of substance on This one, so go, read. Because, when it comes to granting Pharma Any sort of Preemptive Immunity, under Any Heading:



See Also This PLOS collection on: Shameless Disease Mongering.

Audit The Federal Reserve/Wake Up

Try to bear with the 1st 2:20 of bloviating. It does get down to brass tacks after the intro.

Audit The Federal Reserve



6:09: The Obligation is now $9.3 Trillion. And we are Not allowed to find out what the Fed Reserve is doing.

Fed Reserve, Junk Paper IOUs are stealing the Roof over your head and the Food off your plate.

Poisoning and Brain Damaging yourself, to get Happy about it makes as much sense as cutting your foot off to cure an ingrown toenail:

Especially when your 'Mental Health' Professional is peddling Dope which peddles Itself through the Bullshit of 'Chemical Imbalances', ..... which '$cientists' May, Possibly, Theoretically, Believe/Give a Rat's Ass About, ...... so long as the Chemical Factory CME (Corrupting Medical Education) Research Checks, and Hundreds of $ Millions of Fed Junk Paper, keep rolling in.

SSRI Stories is now at Over 2900 Violent Disasters CAUSED by Antidepressents.

How Much More Violence do we want to Buy: on Credit which is printing us All out into the street?

"Mental Health' is selling You an excess of Your Own Serotonin, and then when All Hell breaks loose Because of that Excess, (Fed Reserve IOU) it's Your Own fault because You're suffering from an Incurable Illness which Psychiatry Admits it knows Jack about Curing, or even discovering the Causes of, yet, ..... The same way it has NEVER known Jack about either.

The CME Grease from the Chemical Factories in our last post should Really Piss you off, ...... once you realize how Little it actually Costs those Chemical Factories to completely corrupt medical education with their Murderous, Incurable, Bull $cience.

You want a 'Cure' for 'Mental Illness' ?

Over the last 100 years, Psychiatry Itself has Created a 1000% Increase in 'Mental Illness' through Poisoning people.

Cut Psychiatry's Money off, ..... and witness a 90% Reduction in 'Mental Illness' and a 33% Reduction in our National Health Care Costs.

Wake Up



If you Still don't get it that Psychiatry is just Rote, By The Numbers Dope Peddling, Electrocuting, Savage On Steroids: see Dr Bonkers:

Schizophrenia Treatment In Seven Easy Steps

Saturday, March 28, 2009

Money Money Money: Who Gets The DRUG MONEY?


Policy and Medicine has:

CME Grant Disclosure 2008

http://www.policymed.com/2009/02/cme-grant-disclosure-2008.html

So if you're in the mood for a Treasure Hunt; Here's some CME Disclosures for 2008 from:

Amgen
AstraZeneca
Glaxo Smith Kline
Johnson & Johnson's companies
Eli Lilly
Merck
Pfizer


And if you missed This Next one: GO, Post Haste, to Beyond Meds.

Biederman Busted Big Time

Major Hat Tip to Gianna

Thursday, March 26, 2009

Psychiatry & its 1000% Increase OF 'Mental Illness'

We've recently added 2 remarkable, free PDF downloads to our link list.

You Don't have to be a Neuroscientist to understand them. They are Brief, plainly written, and Right to the point. Together they will teach you Everything you Need to know about the Lethal Junk Science of Psychiatry, ..... in a Half Hour or less.

Anatomy Of An Epidemic * by Robert Whitaker, 13 pages in length

Suicides and Psychiatric Drugs by Janne Larsson, 14 pages in length

Mr Whitaker concludes with:
A century ago, fewer than two people per 1,000 were considered to be"disabled" by mental illness and in need of hospitalisation. By 1955, that number had jumped to 3.38 people per 1,000, and during the past 50 years, a period when psychiatric drugs have been the cornerstone of care, the disability rate has climbed steadily, and has now reached around 20 people per 1,000. (Table 2). As with any epidemic, one would suspect that an outside agent of some type-a virus, a bacterial infection, or an environmental toxin was causing this rise in illness. That is indeed the case here. There is an outside agent fueling this epidemic of mental illness, only it is to be found in the medicine cabinet. Psychiatric drugs perturb normal neurotransmitter function, and while that perturbation may curb symptoms over a short term, over the long run it increases the likelihood that a person will become chronically ill, or ill with new and more severe symptoms. A review of the scientific literature shows quite clearly that it is our drug-based paradigm of care that is fueling this modem-day plague.
From 2 to 20 is a 1000% Increase.

From Chapter 14 (pg 13) of Larsson's Report
The officials at the National Board of Health and Welfare know that the psychiatric drugs can induce suicidality or increased suicidality (especially in the beginning, when doses are increased/lowered, when other drugs are added, or during the withdrawal phase). They are aware about the now accepted serious harmful drug effect akathisia as an underlying cause in cases of suicide and violence against others. They know that serious physical and mental conditions can be caused by the use of several psychiatric drugs at the same time and, as written before, the “adequate drug treatment” among the persons committing suicide was on the average four different psychiatric drugs the preceding year. There is in the material submitted to the Board about the treatment an abundance of evidence that harmful effects induced by the drugs are seen as even more “symptoms” – and that these harmful effects are then handled with even more drugs, with a fatal outcome.

But the psychiatric drugs are not challenged. No questions are asked about their role in the subsequent suicides. And the very reason for this is that old myths about the protective effect of antidepressants and neuroleptics against suicide – directly taken from the false marketing material of the pharmaceutical companies – still govern the activities at the top of the National Board of Health and Welfare.

The paradigm of Psychiatric 'Care' is to Misinterpret the Direct, Behavioral Toxicity which Psychiatric Drugs CAUSE in a person as evidence that the person is Ill-er than even the Ideate Peddling the Toxic Drugs had known, ...... in order to Profitably Sell their Victim even More of the Toxic Drug which Caused the Person's Behavior to Deteriorate in the First Place.

We're Re Running these 3 Videos in case You're New here. Neuroleptics/Antipsychotics CAUSE the Tardive Dyskinesias and Tardive Dystonias displayed in them.

Tardive Dystonia



Tardive Dyskinesia





Abilify
Geodon
Clozapine
Seroquel
Risperdal
Zyprexa

Are Neuroleptic/Antipsychotic Poisons.

Here, http://www.psychiatrictimes.com/clinical-scales/movement_disorders#_

at Psychiatric Times: Dr. Jay Pomerantz offers downloadable forms to score the Damage that Antipsychotics inflict.
"The original publication of the AIMS is often cited as: Guy W. ECDEU Assessment Manual for Psychopharmacology, Rockville, MD, US Department of Health, Education, and Welfare, 1976."
AIMS and the Damage Psychiatry records with it is nothing "unknown" to The Industry which the FDA is Supposed to be overseeing. Nor is AIMS unknown to the US Dept of Health, Education, and Welfare, ..... SINCE 1976:

33 YEARS ago. BUT:

From FDA, 30 years later:
"The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown."
10/06/2006: pg 13
"There is no known treatment for established cases of tardive dyskinesia, although the syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn. Antipsychotic treatment, itself, however, may suppress (or partially suppress) the signs and symptoms of the syndrome and thereby may possibly mask the underlying process. The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown. (since 1976)
page 25

Associated With Discontinuation of Treatment
"Suicide attempt was associated with discontinuation in 1.2% of RISPERDAL®-treated patients compared to 0.6% of placebo patients, but, given the almost 40-fold greater exposure time in RISPERDAL® compared to placebo patients, it is unlikely that suicide attempt is a RISPERDAL®-related adverse event (see PRECAUTIONS)"
A 100% Increase?

Page 38:

Physical and Psychological Dependence
RISPERDAL® has not been systematically studied in animals or humans for its potential for abuse, tolerance, or physical dependence.
But out of the blue is a 100% Increase in Suicidal Behavior upon Discontinuation. Ohhh-K.

Page 41:

Pediatric Use
The safety and effectiveness of RISPERDAL® in pediatric patients with schizophrenia have not been established.

1 FDA Year Later:

08/22/2007: Patient Population Alerted Label

Page 30

8.4 Pediatric Use
"The efficacy and safety of RISPERDAL® in the treatment of schizophrenia were demonstrated in 417 adolescents, aged 13 – 17 years, in two short-term (6 and 8 weeks, respectively) double- blind controlled trials"
Page 27

6.9 Postmarketing Experience
"Other adverse events reported since market introduction, which were temporally related to RISPERDAL® but not necessarily causally related, include the following: pancreatitis, pituitary adenoma, pulmonary embolism, precocious puberty, cardiopulmonary arrest, and sudden death."
That is one Fascinating Interpretation of the word "Safety" in Any language.

* The Drug epidemic begins in 1955 w/3.38 per 1000. Note that Mr Whitaker's work was published in Spring of 2005. The percentage may be above 1000% today, in 2009.

Saturday, March 21, 2009

ECT: Glissando Treatment Reduces Chance Of Fracture













Psychquotes.com has:
"We need a program of psychosurgery for political control of our society. The purpose is physical control of the mind. Everyone who deviates from the given norm can be surgically mutilated. The individual may think that the most important reality is his own existence, but this is only his personal point of view. . . Man does not have the right to develop his own mind. . . . We must electronically control the brain. Someday armies and generals will be controlled by electronic stimulation of the brain."
Dr. Jose M.R. Delgado, Director of Neuropsychiatry at Yale University Medical School, Congressional Record, No. 26, Vol. 118, Feb. 24, 1974. Delgado was reported as part of the "MK-Ultra" CIA mind-control program.

Wednesday, March 18, 2009

Ray Sandford: The FORCED Electrocution Continues



mindfreedom.org/ray has:

Campaign To End Forced Outpatient Electroshock Of Ray Sandford

The powers that be, in Minnesota, do not wish to open a discussion about it.

We watched this vid at a friend's blog, and commented.

Opening a Dialogue, With Govt, on the barbarism perpetrated on Mr Sandford would reflect unfavorably On Govt. itself, ..... looking out, For itself.

Ray is Not the only person Providing $50 Thousand Dollars a month for an army of State Funded Employees, and putting Them under Public scrutiny would put the entire State Mental Health System under Public scrutiny.

And With that Scrutiny would come the Loss of $ Millions of Dollars in Federal and State Funding to keep those State employees on board, as part of Govt's own "You watch my back, I'll watch your's" life support mechanism.

If you believe that ECT is Not a barbarism: Check the Electrical Output of ECT Machines, Again. If this is being Done to Ray, it Can be Done to You.




Other blogs are Also supporting Ray's Inalienable Rights, by Exposing the Violation Of Ray's Inalienable Rights. We'll gladly link to you if you want to help out. Drop us a comment.

Is Something Not Quite Right With Stan

Rayne's World

Soulful Sepulcher

JustAna

Beyond Meds

Naturalgal's Weblog

Invincible Summers

Different Thoughts

The Trouble with Spikol

Discover And Recover

We also suggest that you go to ant.com/toolbar and download their free toolbar add on for Internet Explorer or Firefox, which will allow you to Save this Video to your hard drive, in case the original vid becomes unavailable.

And on e-mailing your concerns to Elected Officials:

Do so, but Follow that e-mail up with a Written letter. In politics e-mails often get deleted unread, wholesale, because politicians get Too many of them as it is to even Bother reading most of them.

PS: Ray may have misspoken the $ Dollar cost from $2,500 per shock up to $25,000 BUT: We're betting that if You add up All the costs of the supporting Mental Health Bureaucracy contributing to the 40 times this has been done to Ray, he's not far off at $25K per shock.

Tuesday, March 17, 2009

Giant Crabs & Bullshit

How have AZ's McFadden, and all the Rest of Psych's Poison Package Bullshitters been allowed to Steely Dan Western Civ for So long, ..... in the 1st place? BNET has the AZ details.

$cientist Bullshit



Chemical Factory Bullshit

Psychdrugdangers.com has:

The "Chemical Imbalance" Myth

"If you tell a lie big enough and keep repeating it, people will eventually come to believe it."

Joseph Goebbels

And Then There's This Letter.


If The Programs and Services it is Advocating for, on Your Money, include the Involuntary Poisoning of Anyone's Chemical Imbalance, based on the Above Bullshit, the principle involved is Not Bullshit. It's Tyranny.

For more on Mr Mayberg refer back to TMAP: Players Part I

For more on TMAP refer back to:

Risperdal: The Eyes Of Texas Are Upon You, where in Texas 2nd petition against J&J/Janssen we saw a Lot of words, and Bullshit wasn't among them. So We gotta figure that the Texas Attorney General Isn't just talking Bullshit about $436 Million Dollars of Alleged Medicaid Fraud.

And we Still haven't tossed this shipload of, ..... uhhh, ...... Tea, into the Harbor, ..... Why?

A Whole Lotta Bullshit



And Finally, see This crock of Bullshit:

Half Of Young Adults Have Mental Disorder

..... Overall, the authors note, the rate of psychiatric disorders is high among young adults, who are at a vulnerable stage of development.

“The vast majority of disorders in this population can be effectively treated with evidence-based psychosocial and pharmacological approaches,” they conclude.

“Early treatment could reduce the persistence of these disorders and their associated functional impairment, loss of productivity and increased health care costs. As these young people represent our nation’s future, urgent action is needed to increase detection and treatment of psychiatric disorders among college students and their non–college-attending peers.”

Saturday, March 14, 2009

Snidely Whiplash Owns The Library Mortgage

DSM-Conflicts-Of-Interest-2006

The 2006 Cosgrove/Krimsky study of Drug Money Conflicting those who hold a Drug Money Interest in Peddling Incurable Bio-$cience, ...... should disabuse you of Any Fantasies surrounding the Dispassionate Nature of DSM Bio-Billing Objectivity, ...... which remains, in a Fox Mulder sort of way, 'Out There', ...... Way out there.

Altering Brain and Body chemistry produces Disease, Hellish Confusion, Psychotic Meltdowns, and Death.

Why do University Psychiatric programs/researchers Continue to produce Disease, Hellish Confusion, Psychotic Meltdowns, and Death?

The Washington Post has:

When Science Is A Siren Song
..... "Part of the problem is that we've been conditioned to trust university research. It is based, after all, on the presumably lofty motives of its practitioners. What's not to like about science carried out by academics who have nobly dedicated their lives to understanding the unknown, furthering knowledge and serving humanity?

Within academia's ivied walls, the view is a bit different. The university is not a peaceable kingdom, and life is far more Hobbesian. Henry Kissinger was on to something when he observed that "university politics are so vicious precisely because the stakes are so small." In contrast to the academia-vs.-industry trope, hubris, self-interest and ambition are not checked at the university door; arguably, they are essential for admission and required for professional success.

University researchers are in a constant battle for recognition and the rewards associated with success: research space, speaking engagements, funding and autonomy. Consequently, while academic research is often described as "curiosity-driven," the reality is messier, as (curiously) many researchers tend to pursue the trendiest technologies and explore topics that happen to be associated with the most generous levels of research support.

Moreover, since academic success is determined almost exclusively by the number and prestige of research publications, the incentives to generate results are exceedingly powerful and can encourage investigators to see patterns that may not exist, to disregard contradictory observations that might be important, to overvalue data that might be preliminary or unreliable, and to embrace conclusions that deserve to be viewed with far greater skepticism. .....

Also see these recent posts:

Alison Bass: who has discovered an Elephant sized Fly in Massachusetts Medical Research & Publication.

Massachusetts Fraud Case Exposes Deep Flaws

And Cl Psych: on Pharma Pimp writing:

Abilify, Depression, And The Memory Hole

The hat tip on the Wash Post piece goes to University Diaries.

Thursday, March 12, 2009

US DOJ: BACKLOGGED For Years Investigating PHARMA FRAUD

News Inferno has:

Feds Join Lawsuit Alleging Natrecor Was Illegally Marketed

Scios & its Parent Co. Johnson and Johnson, who are also the Parent of Janssen/Risperdal, are again accused of Off Label Marketing.

The investigation was conducted by:

1: Civil Division of the U.S. DOJ
2: U.S. Attorney’s Office for the Northern District of California
3: Federal Bureau of Investigation
4: Offices of Inspector General of the Department of Health and Human Services
5: FDA
6: Department of Veterans Affairs
7: Office of Personnel Management
8: Department of Defense
.


Kaisernetwork.org from last July has:

More Than 500 Backlogged Whistle-Blower Cases Allege Health Care, Drug Company Fraud
"Whistle-blower lawsuits alleging that pharmaceutical companies and government contractors defrauded the federal government have created a backlog of more than 900 cases at the Department of Justice, the Washington Post reports. According to the Post, more than 500 of the cases involve the health care and pharmaceutical industries, as well as Medicare and Medicaid.

Patrick Burns, a spokesperson for Taxpayers Against Fraud, said, "Even if no new cases are filed, it might take 10 years for the Department of Justice to clear its desk.

Lawyers involved in the backlogged disputes say DOJ "cannot keep pace with the surge in charges brought by whistle-blowers," the Post reports. Since 2001, 300 to 400 civil cases have been filed each year; however, the 75-lawyer unit that reviews the allegations investigates about 100 cases annually. Whistle-blowers routinely wait 14 or more months to find out whether DOJ will get involved in the case, during which time whistle-blowers are not allowed to discuss or disclose the existence of such disputes. The government rejects about three-quarters of the cases it receives, saying the majority lack merit.

Perhaps, ...... if NIH quit funding CRAP Clinical Depression Research our DOJ wouldn't have such a ton of work already on its plate.

And what IS Clinical Depression anyway?

Clinical Depression - in 'Regular English' means that You went to a Clinic, and a Clinician decided You were Depressed, Wrote it down, Sold you a Steaming Pile of Incurable Diagnosis, and Ripped off Your Money, Health, and Rights, to Sell you an Illness.

And even With antidepressants you'll probably Still be depressed, because:

Their long term efficacy leaves almost Everything, ..... Except a Life Time Vampire in your neck, ..... to be desired. Don't Think So? See our post on Schizophrenic Fish ..... and Prozac's Inability to even inhibit long term displays of aggression in the $10.99 brain of an aquarium fish.

Oops, Sorry. Those are TAX FUNDED fish: which means You probably got 'Mental Healthed' for a Whole lot More than $10.99 apiece on yet Another, already documented that It Don't Work, ..... 'Mental Health' Investigative Rerun.

And with Due Deference to All those tireless and well intentioned bloggers who are Ripping the Death Mask clean off of this Bio-$cience, ...... will Someone Please, ...... tell us Where, and in Which Anatomy Textbook, ...... Any Human Carcass contains a 'Wellness' which requires 'Treating' through BRAIN DAMAGE to achieve 'Mental Health'?

Read Charlotte Iserbyt again on Change Agents, ...... and understand that Wellness is not only bad grammar, but an agenda evacuated bag of linguistic methane.

People, ...... you Do own a Whole Slather of organs, ..... which can be damaged or destroyed by Expensive Psych Meds, ..... to 'Treat' something you Don't own: ..... a Wellness.

Wednesday, March 11, 2009

Will Food Affect Your Mood?

America's farmers and ranchers have been and are getting a very raw deal, ..... and once Ahh (corporate financial) gain, it's through centrist, Central Planning: where neither the farmers, ranchers, Nor city dwellers, mean anything beyond Jack, Jack's Money, and Squat.

Look up some of the Sweetheart Deals and Compensation Figures previous Central Planners, have landed, right out of office, right here. Chemical factories have Become our Govt. And It goes Way beyond just the FDA.

Meet The Proud Political Junkie's Gazette

While Tax Fed Researchers in their Ivory Tower Psych Fiefdoms recycle Endless Drug Co Advertising Funded Theories of non-existent 'Chemical and Genetic Imbalances' in Your Brain, in order to Sell you Drugs which Damage your Brain, ...... and salve their Own useless egos,

Go get Yourself on over to:

www.naisstinks.com/index.php?con=tool_kit

and download the New NAIS Toolkit, ...... and see what's got these folks worked up.

Because even if you Are a Tax Funded, Ivory Tower Researcher recycling Endless, Worn Out Drug Company Advertising CRAP, you may find Yourself and Your Own Kids soon suffering a Whole Body Imbalance, due to: A yet Further Excess Of Bureaucrats who have Never Yet produced a scrap of the Food on Your Plate, ..... Ever, ...... 3 times a day.

S. 301 Physician Payments Sunshine Act Of 2009

On Jan 22 2009 S. 301 was introduced.

http://thomas.loc.gov/cgi-bin/query/z?c111:S.301:

has:

Physician Payments Sunshine Act of 2009 (Introduced in Senate)

S 301 IS

111th CONGRESS
1st Session

S. 301

To amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.

IN THE SENATE OF THE UNITED STATES

January 22, 2009

Mr. GRASSLEY (for himself, Mr. KOHL, and Ms. KLOBUCHAR) introduced the following bill; which was read twice and referred to the Committee on Finance


A BILL

To amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.

    Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the `Physician Payments Sunshine Act of 2009'.

SEC. 2. TRANSPARENCY REPORTS AND REPORTING OF PHYSICIAN OWNERSHIP OR INVESTMENT INTERESTS.

    Part A of title XI of the Social Security Act (42 U.S.C. 1301 et seq.) is amended by inserting after section 1128F the following new section:

`SEC. 1128G. TRANSPARENCY REPORTS AND REPORTING OF PHYSICIAN OWNERSHIP OR INVESTMENT INTERESTS.

    `(a) Transparency Reports-
      `(1) PAYMENTS OR OTHER TRANSFERS OF VALUE-
        `(A) IN GENERAL- Except as provided in subsection (e), on March 31, 2011, and on the 90th day of each calendar year beginning thereafter, any applicable manufacturer that provides a payment or other transfer of value to a covered recipient (or to an entity or individual at the request of or designated on behalf of a covered recipient), shall submit to the Secretary, in such electronic form as the Secretary shall require, the following information with respect to the preceding calendar year:
          `(i) The name of the covered recipient.
          `(ii) The business address of the covered recipient and, in the case of a covered recipient who is a physician, the specialty and Medicare billing number of the covered recipient.
          `(iii) The value of the payment or other transfer of value.
          `(iv) The dates on which the payment or other transfer of value was provided to the covered recipient.
          `(v) A description of the form of the payment or other transfer of value, indicated (as appropriate for all that apply) as--
            `(I) cash or a cash equivalent;
            `(II) in-kind items or services;
            `(III) stock, a stock option, or any other ownership interest, dividend, profit, or other return on investment; or
            `(IV) any other form of payment or other transfer of value (as defined by the Secretary).
          `(vi) A description of the nature of the payment or other transfer of value, indicated (as appropriate for all that apply) as--
            `(I) consulting fees;
            `(II) compensation for services other than consulting;
            `(III) honoraria;
            `(IV) gift;
            `(V) entertainment;
            `(VI) food;
            `(VII) travel;
            `(VIII) education;
            `(IX) research;
            `(X) charitable contribution;
            `(XI) royalty or license;
            `(XII) current or prospective ownership or investment interest;
            `(XIII) compensation for serving as faculty or as a speaker for a continuing medical education program;
            `(XIV) grant; or
            `(XV) any other nature of the payment or other transfer of value (as defined by the Secretary).
          `(vii) If the payment or other transfer of value is related to marketing, education, or research specific to a covered drug, device, biological, or medical supply, the name of that covered drug, device, biological, or medical supply.
          `(viii) Any other categories of information regarding the payment or other transfer of value the Secretary determines appropriate.
        `(B) AGGREGATE REPORTING- Information submitted by an applicable manufacturer under subparagraph (A) shall include the aggregate amount of all payments or other transfers of value provided by the applicable manufacturer to covered recipients (and to entities or individuals at the request of or designated on behalf of a covered recipient) during the preceding year.
        `(C) SPECIAL RULE FOR CERTAIN PAYMENTS OR OTHER TRANSFERS OF VALUE- In the case where an applicable manufacturer provides a payment or other transfer of value to an entity or individual at the request of or designated on behalf of a covered recipient, the applicable manufacturer shall disclose that payment or other transfer of value under the name of the covered recipient.
      `(2) PHYSICIAN OWNERSHIP- In addition to the requirement under paragraph (1)(A), on March 31, 2011, and on the 90th day of each calendar year beginning thereafter, any applicable manufacturer or applicable group purchasing organization shall submit to the Secretary, in such electronic form as the Secretary shall require, the following information regarding any ownership or investment interest (other than an ownership or investment interest in a publicly traded security and mutual fund, as described in section 1877(c)) held by a physician (or an immediate family member of such physician (as defined for purposes of section 1877(a))) in the applicable manufacturer or applicable group purchasing organization during the preceding year:
        `(A) The dollar amount invested by each physician holding such an ownership or investment interest.
        `(B) The value and terms of each such ownership or investment interest.
        `(C) Any payment or other transfer of value provided to a physician holding such an ownership or investment interest (or to an entity or individual at the request of or designated on behalf of a physician holding such an ownership or investment interest), including the information described in clauses (i) through (viii) of paragraph (1)(A), except that in applying such clauses, `physician' shall be substituted for `covered recipient' each place it appears.
        `(D) Any other information regarding the ownership or investment interest the Secretary determines appropriate.
    `(b) Penalties for Noncompliance-
      `(1) FAILURE TO REPORT-
        `(A) IN GENERAL- Subject to subparagraph (B), except as provided in paragraph (2), any applicable manufacturer or applicable group purchasing organization that fails to submit information required under subsection (a) in a timely manner in accordance with rules or regulations promulgated to carry out such subsection, shall be subject to a civil money penalty of not less than $1,000, but not more than $10,000, for each payment or other transfer of value or ownership or investment interest not reported as required under such subsection. Such penalty shall be imposed and collected in the same manner as civil money penalties under subsection (a) of section 1128A are imposed and collected under that section.
        `(B) LIMITATION- The total amount of civil money penalties imposed under subparagraph (A) with respect to each annual submission of information under subsection (a) by an applicable manufacturer or applicable group purchasing organization shall not exceed $150,000.
      `(2) KNOWING FAILURE TO REPORT-
        `(A) IN GENERAL- Subject to subparagraph (B), any applicable manufacturer or applicable group purchasing organization that knowingly fails to submit information required under subsection (a) in a timely manner in accordance with rules or regulations promulgated to carry out such subsection, shall be subject to a civil money penalty of not less than $10,000, but not more than $100,000, for each payment or other transfer of value or ownership or investment interest not reported as required under such subsection. Such penalty shall be imposed and collected in the same manner as civil money penalties under subsection (a) of section 1128A are imposed and collected under that section.
        `(B) LIMITATION- The total amount of civil money penalties imposed under subparagraph (A) with respect to each annual submission of information under subsection (a) by an applicable manufacturer or applicable group purchasing organization shall not exceed $1,000,000.
      `(3) USE OF FUNDS- Funds collected by the Secretary as a result of the imposition of a civil money penalty under this subsection shall be used to carry out this section.
    `(c) Procedures for Submission of Information and Public Availability-
      `(1) IN GENERAL-
        `(A) ESTABLISHMENT- Not later than November 1, 2009, the Secretary shall establish procedures--
          `(i) for applicable manufacturers and applicable group purchasing organizations to submit information to the Secretary under subsection (a); and
          `(ii) for the Secretary to make such information submitted available to the public.
        `(B) DEFINITION OF TERMS- The procedures established under subparagraph (A) shall provide for the definition of terms (other than those terms defined in subsection (g)), as appropriate, for purposes of this section.
        `(C) PUBLIC AVAILABILITY- The procedures established under subparagraph (A)(ii) shall ensure that, not later than September 30, 2011, and on June 30 of each calendar year beginning thereafter, the information submitted under subsection (a) with respect to the preceding calendar year is made available through an Internet website that--
          `(i) is searchable and is in a format that is clear and understandable;
          `(ii) contains information that is presented by the name of the applicable manufacturer or applicable group purchasing organization, the name of the covered recipient, the business address of the covered recipient, the specialty of the covered recipient, the value of the payment or other transfer of value, the date on which the payment or other transfer of value was provided to the covered recipient, the form of the payment or other transfer of value, indicated (as appropriate) under subsection (a)(1)(A)(v), the nature of the payment or other transfer of value, indicated (as appropriate) under subsection (a)(1)(A)(vi), and the name of the covered drug, device, biological, or medical supply, as applicable;
          `(iii) contains information that is able to be easily aggregated and downloaded;
          `(iv) contains a description of any enforcement actions taken to carry out this section, including any penalties imposed under subsection (b), during the preceding year;
          `(v) contains background information on industry-physician relationships;
          `(vi) in the case of information submitted with respect to a payment or other transfer of value described in subsection (e), lists such information separately from the other information submitted under subsection (a) and designates such separately listed information as funding for clinical research;
          `(vii) contains any other information the Secretary determines would be helpful to the average consumer; and
          `(viii) provides the covered recipient an opportunity to submit corrections to the information made available to the public with respect to the covered recipient.
      `(2) CONSULTATION- In establishing the procedures under paragraph (1), the Secretary shall consult with the Inspector General of the Department of Health and Human Services, affected industry, consumers, consumer advocates, and other interested parties in order to ensure that the information made available to the public under such paragraph is presented in the appropriate overall context.
    `(d) Annual Reports and Relation to State Laws-
      `(1) ANNUAL REPORT TO CONGRESS- Not later than April 1 of each year beginning with 2011, the Secretary shall submit to Congress a report that includes the following:
        `(A) The information submitted under subsection (a) during the preceding year, aggregated for each applicable manufacturer and applicable group purchasing organization that submitted such information during such year.
        `(B) A description of any enforcement actions taken to carry out this section, including any penalties imposed under subsection (b), during the preceding year.
      `(2) ANNUAL REPORTS TO STATES- Not later than April 1 of each year beginning with 2011, the Secretary shall submit to States a report that includes a summary of the information submitted under subsection (a) during the preceding year with respect to covered recipients in the State.
      `(3) RELATION TO STATE LAWS-
        `(A) IN GENERAL- Effective on January 1, 2010, subject to subparagraph (B), the provisions of this section shall preempt any law or regulation of a State or of a political subdivision of a State that requires an applicable manufacturer (as defined in subsection (g)) to disclose or report information (as described in subsection (a)) regarding a payment or other transfer of value provided by the applicable manufacturer to a covered recipient (as so described).
        `(B) NO PREEMPTION OF ADDITIONAL REQUIREMENTS- Subparagraph (A) shall not preempt any law or regulation of a State or of a political subdivision of a State that requires the disclosure or reporting of information not required to be disclosed or reported under this section.
    `(e) Delayed Reporting for Payments Made Pursuant to Product Development Agreements and Clinical Investigations- In the case of a payment or other transfer of value made to a covered recipient by an applicable manufacturer pursuant to a product development agreement for services furnished in connection with the development of a new drug, device, biological, or medical supply, or by an applicable manufacturer in connection with a clinical investigation, the applicable manufacturer may report the value of such payment or other transfer of value in the first reporting period under subsection (a) after the earlier of the following:
      `(1) The date of the approval or clearance of the covered drug, device, biological, or medical supply by the Food and Drug Administration.
      `(2) Two calendar years after the date such payment or other transfer of value was made.
    `(f) Implementation-
      `(1) CONSULTATION- The Secretary shall consult with the Inspector General of the Department of Health and Human Services on the implementation of this section.
      `(2) LIMITATION ON REVIEW- There shall be no judicial review of the implementation of this section.
    `(g) Definitions- In this section:
      `(1) APPLICABLE GROUP PURCHASING ORGANIZATION- The term `applicable group purchasing organization' means a group purchasing organization (as defined by the Secretary) that purchases, arranges for, or negotiates the purchase of a covered drug, device, biological, or medical supply.
      `(2) APPLICABLE MANUFACTURER- The term `applicable manufacturer' means a manufacturer of a covered drug, device, biological, or medical supply.
      `(3) CLINICAL INVESTIGATION- The term `clinical investigation' means any experiment involving 1 or more human subjects in which a drug or device is administered, dispensed, or used.
      `(4) COVERED DEVICE- The term `covered device' means any device for which payment is available under title XVIII or a State plan under title XIX or XXI (or a waiver of such a plan).
      `(5) COVERED DRUG, DEVICE, BIOLOGICAL, OR MEDICAL SUPPLY- The term `covered drug, device, biological, or medical supply' means any drug, biological product, device, or medical supply for which payment is available under title XVIII or a State plan under title XIX or XXI (or a waiver of such a plan).
      `(6) COVERED RECIPIENT- The term `covered recipient' means the following:
        `(A) A physician.
        `(B) A physician medical practice.
        `(C) A physician group practice.
      `(7) EMPLOYEE- The term `employee' has the meaning given such term in section 1877(h)(2).
      `(8) KNOWINGLY- The term `knowingly' has the meaning given such term in section 3729(b) of title 31, United States Code.
      `(9) MANUFACTURER OF A COVERED DRUG, DEVICE, BIOLOGICAL, OR MEDICAL SUPPLY- The term `manufacturer of a covered drug, device, biological, or medical supply' means any entity which is engaged in the production, preparation, propagation, compounding, conversion, processing, marketing, or distribution of a covered drug, device, biological, or medical supply (or any subsidiary of or entity affiliated with such entity).
      `(10) PAYMENT OR OTHER TRANSFER OF VALUE-
        `(A) IN GENERAL- The term `payment or other transfer of value' means a transfer of anything of value and includes, subject to subparagraph (B), without limitation, any compensation, gift, honorarium, speaking fee, consulting fee, travel, services, dividend, profit distribution, stock or stock option grant, or ownership or investment interest.
        `(B) EXCLUSIONS- An applicable manufacturer shall not be required to submit information under subsection (a) with respect to the following:
          `(i) Any payment or other transfer of value provided by an applicable manufacturer to a covered recipient where the aggregate amount transferred to, requested by, or designated on behalf of the covered recipient does not exceed $100 during the calendar year. Such aggregate amount shall be determined without taking into account any payment or other transfer of value described in clauses (ii) through (ix).
          `(ii) Product samples that are not intended to be sold and are intended for patient use.
          `(iii) Educational materials that directly benefit patients or are intended for patient use.
          `(iv) The loan of a covered device for a short-term trial period, not to exceed 90 days, to permit evaluation of the covered device by the covered recipient.
          `(v) Items or services provided under a contractual warranty, including the replacement of a covered device, where the terms of the warranty are set forth in the purchase or lease agreement for the covered device.
          `(vi) A transfer of anything of value to a covered recipient when the covered recipient is a patient and not acting in the professional capacity of a covered recipient.
          `(vii) Discounts (including rebates).
          `(viii) In-kind items used for the provision of charity care.
          `(ix) A dividend or other profit distribution from, or ownership or investment interest in, a publicly traded security and mutual fund (as described in section 1877(c)).
      `(11) PHYSICIAN- The term `physician' has the meaning given that term in section 1861(r). For purposes of this section, such term does not include a physician who is an employee of the applicable manufacturer that is required to submit information under subsection (a).'.

Monday, March 9, 2009

FDA Commissioners: The Last 20 Years: A Primer Part I

The FDA Identity of Past FDA Commissioners is at:

fda.gov/oc/commissioners/default.htm

Andrew C von Eschenbach, M.D. 12/13/2006 - 1/20/2009.

The US House Energy & Commerce Committee has documents re: their investigations into this dysfunctional Agency at:

http://energycommerce.house.gov/Investigations/FDADrugSafety.shtml

http://energycommerce.house.gov/FDAGlobalAct-08/index.shtml

For further analysis of FDA's recent 'World's Gold Standard Preempt-ocrat' Supreme Court Slapdown see:

Pharmalittle:

Further Thoughts On Wyeth V. Levine
Supreme Court Rejects FDA Preemption - Nine To Nothing.


Forward, Into The Past.

Lester M Crawford D.V.M. 7/18/2005 - 9/23/2005

2002: Statement by Lester M Crawford Re: PDUFA (Prescription Drug User Fee Act)

$1.2 Billion in Drug Money Profits Cost Drug Companies $133 Million in Drug Money "User Fee" Payouts.
"..... The pharmaceutical industry also enjoys significant R&D savings as a result of shorter review times. Under PDUFA, FDA reduced new drug review by 12 months. Each month of reduced review results in an average saving of $2.5 million, or $30 million in R&D cost savings over 12 months. Given that FDA approves an average of 40 NMEs and biologics per year, the savings to industry represent $1.2 billion annually. The program represents a bargain in light of the $133 million that industry paid in user fees in FY2001. ...... "
2003: Institute of Medicine Elects 65 New Members 5 Foreign Associates
Date: Oct. 27, 2003
Contacts: Christine Stencel, Media Relations Officer
202-334-2138; e-mail
Jana Surdi, Director, IOM Council and Membership Office
202-334-2174; e-mail

FOR IMMEDIATE RELEASE

Institute of Medicine Elects 65 New Members, Five Foreign Associates

WASHINGTON -- The Institute of Medicine of the National Academies today announced the names of its 65 newly elected members, raising the Institute's total active membership to 1,382. In addition, the Institute honored five individuals by election to foreign associate membership, bringing the total members in that category to 71.

"It is a great pleasure to welcome these distinguished and influential individuals to the Institute of Medicine," said IOM President Harvey V. Fineberg. "Members are elected through a highly selective process that recognizes those who have made major contributions to the advancement of the medical sciences, health care, and public health. Election is considered one of the highest honors in the fields of medicine and health."

Current active members elect new members from among candidates nominated for their professional achievement and commitment to service. An unusual diversity of talent among members is assured by the Institute's charter, which stipulates that at least one-quarter be selected from outside the health professions, from such fields as the natural, social, and behavioral sciences, as well as law, administration, engineering, and the humanities.
Ed. note: This is the subversion through Law, Administration and Engineering of Your Inalienable Rights to promote social, behavioral (junk) science, and the humanities, ..... which remain what they've Always been: Political Opinions.
The Institute of Medicine is unique for its structure as both an honorific membership organization and an analytic and advisory organization. Established in 1970 by the National Academy of Sciences, the Institute has become recognized as a national resource for independent, scientifically informed analysis and recommendations on issues related to human health. With their election, members make a commitment to devote a significant amount of volunteer time as members of IOM committees, which engage in a broad range of studies on health policy issues.

Current projects of the Institute include: an assessment of evidence on the potential benefits and risks of testosterone replacement therapy, and of whether clinical trials should be conducted and how; a review of the current state of knowledge and policy regarding spinal cord injury; a study to assess the factors responsible for the epidemic of obesity in children, and to develop an action plan to decrease its prevalence; a project examining how to address the public's lack of "health literacy"; and a study exploring patterns of malaria and malarial drug resistance, with the aim of developing policy strategies that could lead to better treatment.

Reports from the Institute completed in the past year include: Childhood Cancer Survivorship: Improving Care and Quality of Life, a report on the quality of care experienced by childhood cancer survivors, and their long-term health outlook; Microbial Threats to Health: Emergence, Detection, and Response, which examines the complexities and challenges posed by infectious diseases such as SARS, and the trends that contribute to the emergence of these threats; Financing Vaccines in the 21st Century: Assuring Access and Availability, which recommends that government change its role from merely purchasing vaccines to ensuring immunization for all citizens through a new publicly funded insurance mandate and voucher plan; Hidden Costs, Value Lost: Uninsurance in America, a report that estimates the potential value of improved health outcomes expected to be gained from expanded insurance coverage to range from $65 billion to $130 billion annually; and Leadership by Example: Coordinating Government Roles in Improving Health Care Quality, which calls for stronger federal actions to improve the quality of health care and proposes a rigorous implementation strategy for achieving this.

This, is GOVT/Industry Collusion Assuring that 1 in Every 5 of You Need to be, and Will be, Addicted to a Lifetime of Brain and CNS Damaging chemicals, ....... at Your Own Expense, ...... by Behavioral $cientists. PDUFA itself, where Pharma Money 'Speeds' approval of Pharma's chemicals into Your Brain and body, and Your money into GOVT/Industry colluding Pharma coffers, can be found at:

FDA.gov/oc/pdufa

The National Acadamies have:

2006: Medication Errors Injure 1.5 Million People and Cost Billions Of Dollars Annually

Back to the Veterinarian in Chief

2005: A Conspiracy Of Veterinarians, Women's Health, & Reimported Drugs
"In the July 30, 2002 issue of National Journal's Congress Daily, PhRMA had a full page add quoting Lester M. Crawford, D.V.M. on the dangers of reimporting drugs.

"[Reimportation] would actually create an incentive for unscrupulous individuals to find ways to sell unsafe or counterfeit drugs that, while purported to be from Canada, may actually originate in any part of the world."

"...the threat does not depend upon the nature of the reimported product, but upon the integrity of those handling it."

[The current] "closed regulatory system has been very successful in preventing unapproved, adulterated or misbranded drug products from entering the U.S. stream of commerce. Legislation that would establish other distribution route for products, particularly where those routes routintely transverse a U.S. border, creates a wide inlet for counterfeit drugs and other dangerous products that are potentially injurious to the public health and a threat to the security of our nation's drug supply.

Lester M. Crawford, D.V.M.,
Deputy Commissioner
Food and Drug Administration

Department of Health and Human Services
July 17, 2002

Maybe big PhRMA and the Bush administration couldn't get an M.D. to say it, so they got a veterinarian who would."

2005: Susan Wood Director of FDA Women's Affairs Resigns In Protest See the next link.

2006: Morning After Pill Is Over The Counter?
We'll get to Plan B, and its cervical cancer, later.

2006: Bnet: Crawford Blatantly Violated Principles

Uh Oh, More unreported COI. Followed by:

Wiki:

Justice Department charges

On October 16, 2006, the US Justice Department formally charged Crawford with lying and violating conflict-of-interest laws for falsely reporting his ownership of stock in companies regulated by the FDA. Specifically, according to the charging documents, he falsely stated in a 2004 government filing that shares of Sysco Corp. and Kimberly-Clark Corp. had been sold when he and his wife continued to hold them, and also failed to disclose income from exercising stock options in Embrex Inc. He pleaded guilty the next day.

On February 27, 2007, was sentenced to three years' supervised probation and fines of roughly $90,000.


Hi Ho Medicare Silver! Away!

Mark B. McClennan M.D. Ph.D. 11/14/2002 - 3/26/2004

12/04/2004: The Queens Gazette had:

Majority Of Seniors Will Save $ Under New Rx Program

"Dr. Mark B. McClennan, who heads the Medicare program as administrator of the federal Centers for Medicare and Medicaid, welcomed the study. He said it is part of a growing consensus that the historic new drug program will present many seniors with savings on their prescription drug spending.

McClellan said many people will sign up if for no other reason than they will receive protection against extremely high drug costs and catastrophic illness. This will occur when a Medicare member spends $3,600, the limit in out-of-pocket expenses under the new program, after which he or she would pay only 5 percent of the cost of a prescription.

Under the new plan, the greatest danger of experiencing high out-of-pocket costs will occur when a member reaches the gap in coverage known as the “doughnut hole,” which means the member must pay the entire price for prescriptions until the total expenditures reach $3,600. According to the study, this is expected to happen to about 6.9 million people who already have very high drug costs and no other program that gives them assistance in offsetting these costs."

Hmmm: $3,600 Out of a Senior's Fixed Income IF those pills don't kill them off 1st, as they're making it through the 'Donut Hole' to continue Buying those pills, ....... at 95% Off. And this was a 'Good' idea, as opposed to a 'Bad' idea.

The Number 3 Killer In America Is Iatrogenesis
Have you ever heard of iatrogenesis? The word doesn't even sound that harmful. It comes from two Greek words – iatros – meaning physician, and genesis – meaning created. Yes, the number 3 killer in America is death by doctor. .....

...... But hospitals are dangerous places. The primary reason for people dying unnecessarily in a hospital is the pharmaceutical drug. This is a strange thing to hear. We know that drugs have saved many lives, and we tend to hold the drugs in great esteem. But there is a flipside. Many of the most commonly prescribed drugs are also terrible killers, due to bad patient reactions and the possibility of human error in administering the drugs.

Pharmaceutical drugs are immensely powerful, in a good way and a bad way. Take the right drug at the right time and it will help your illness in a dramatic way. Take the wrong drug at the wrong time and it will kill you on the spot. ......

Hat tip above to justAna.

Visit Ana, and view that beautiful, smiling young woman's portrait.

That portrait is not Ana. That portrait is Traci Johnson, ....... who Iatrogenically Hanged herself at age 19 in Eli Lilly's labs while she was testing their new Wonder chemical duloxetine, Yentreve/Cymbalta, ...... in a clinical trial aimed at garnering FDA approval for the expanded marketing of duloxetine as Yentreve to 'Treat' Stress Urinary Incontinence which Medwatch Data lists as 1 of the 1,989 Different Adverse Events due to duloxetine/Cymbalta 'Treatment', ...... right along with 'Unemployment'. link

For more on Traci Johnson, and the hurried resignation of Veterinarian FDA Commissioner Crawford, See Slate.com:

9/27/2005: What the FDA Isn't Telling.

For more on Cymbalta see the University Of Michigan Depression Center's:

Way Beyond Sadness, brought to you by The Bonkers Institute For Nearly Genuine Research.

Note that U Michigan's Work was Funded by an Unrestricted Educational Grant from Eli Lilly and Co. And so were all those puzzled, pastel faces asking if they Too, might be suffering from the dreaded 'Big D'.

Apparently You Too, were supposed to 'Ask Your Healthcare Professional' whether or not You might be depressed, because your Healthcare Professional is a Professional ideate, and being a Professionally Kickbacked Ideate, They Ideate more profitably than You do.

And for more on Kickbacked Doctors:

Psychrights.org links to NYT's Gardiner Harris for:

Prosecutors Plan Crackdown On Doctors Who Accept Kickbacks


Bloomberg has:

J&J's Janssen Unit Marketed Risperdal Off Label, Ex-Workers Say


And Now; Return Once More With Us To Those Golden Days Of Yesteryear.


Jane E. Henney M.D. 11/17/99 - 1/19/2001

news.muckety.com has:

Dr. Henney's relationship map

NNDB also has a Dr Henney Bio/Map

Healthcare Solutions has Dr Henney appointed:

2003: Senior VP/Provost for Health Affairs, University of Cincinatti

Business Week.com has:

2001: Dr Henney on AstraZeneca's Board Of Directors @ £57,000 per year

All Business.com has:

2002: Amerisource Bergen Elects Jane E Henney M.D. To Its Board Of Directors
"AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital systems/acute care market, alternative care providers, independent community pharmacies, and regional chains.

The company is also a leader in the institutional pharmacy marketplace. With approximately $35 billion in annualized operating revenues, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 13,000 people serving over 25,000 customers."

Forbes.com has Dr. Henney on the Board of Cigna and Amerisource Bergen, along with compensation figures of: (you may have to click past the welcome message)

$493,242.00 at Cigna in 2007 and another

$179,102.00 at AmeriSource Bergen in 2007

In Sept '08 We had:

8,787 Seroquel Lawsuits/Some FDA History

Wherein we briefly addressed Dr Henney's efforts to simplify the Drug Co Product package inserts because they were deemed 'Cumbersome' and Doctors routinely Blew Off reading them.

1: Drug Co. chemicals kill people.

2: Drug Companies could not sell those chemicals without Doctors.

3: Doctors accept Drug Money Kickbacks.

4: Doctors were either too Lazy, or too Stupid, to inform Themselves, on all the possible ways that those chemicals kill people.

5: If those Kickbacked Doctors were held Legally, Punitively Responsible, for killing people through having to Admit that they were Bright enough or Honest enough to actually know the Lethal Truth of those Poisons they are Still Taking Drug Money Kickbacks to kill people with,

The Non $cience of Psychiatry Itself would have to Sneak off into the night the same way its Physician Diversion Fiasco in California did on June 30 2008.

2009: Biopharma and Invivo had package insert simplifier Dr Henney as a possible Return to FDA

Saturday, March 7, 2009

FDA CDRH: Nov 17 2008: The Letter

On November 17 2008 US Representatives John Dingell and Bart Stupak fired this rocket back to then FDA Commissioner Andrew von Eschenbach. We've JPG-ed it from:

energycommerce.house.gov/Press_110/110nr383.shtml

We suggest you save it, print it, and carry it in your wallet.






And then the Next time some Damn Fool tells you that the solution to America's Health Care Crisis lies in "Single Payer, Let GOVT raise Your Taxes to Pay for Everything, National Socialist Bull Hockey", ...... hand that God Damn Fool This letter, ...... and make that God Damn Fool Read This letter back To You, .....

Then ask that God Damn Fool if even MORE OF THIS CRAP is what they Really want, when They or Their Own Family Need Health Care.

At Over $2 Billion Dollars a year FDA has Plenty of budget. What it Needs is to get Rid of its Half a $Billion Dollar "User Fee" addiction which makes Letters like This one an Absolute Inevitability. There Will be more coming. Count on it.

Congressman Dingell and Stupak are Lawfully ELECTED Representatives, Not, APPOINTED Apparatchiks who Unlawfully Intimidate the Real Scientists under them. If you live in either of these Lawfully ELECTED Representative's districts; call their office and say Thank You.

Visit Hissey Kientz LLP on youtube for video clips.

http://www.youtube.com/hkllp

Preventing Crap like this is why we Have a Constitution. Demand it be reinstated, To, ..... The ..... Letter.


"I cannot undertake to lay my finger on that article of the Constitution which granted a right to Congress of expending, on the objects of benevolence, the money of their constituents."

James Madison

Thursday, March 5, 2009

PTSD Meds Killing Soldiers After The Battle

GI Rights News Blog has:

PTSD Meds Killing Soldiers After The Battle
"CHARLESTON, W.Va. -- Stan and Shirley White's son Andrew, a Marine reservist, died at home 2 1/2 years after he returned from Iraq.

Janette Layne lost her husband, Eric, in similar circumstances after his return from Iraq.

More than a year later, they still don't know if the medication their loved ones were taking for post-traumatic stress disorder contributed to their deaths.

Andrew White and Eric Layne were taking Seroquel, Klonopin and Paxil, along with prescription painkillers.

Three other West Virginia servicemen have died in their sleep while undergoing PTSD treatment after returning from Iraq. ........


..... Stan White and (Dr. Fred) Baughman track soldiers and veterans who die in their sleep or slumped at work stations. They contact the families when they hear about such deaths to ask about psychiatric diagnoses and medications. Military casualty officers won't release details.

They found three others from West Virginia. Jeremy Harper, 19, of Dunbar died Jan. 1, 2005, at Walter Reed Army Medical Center while being treated for PTSD. Nicholas Endicott of Logan County, who died at a military hospital in Bethesda, Md., also suffered from PTSD. Derek Johnson, 22, of Hurricane died last year while taking the three drugs.

Baughman notes Seroquel's link to fatal heart arrhythmias and irregularities. He's now researching the death of Chad Oligschlaeger, 21, a Texas Marine who died in May while taking six medications for PTSD, including Seroquel.

"I'm telling you right now, these drugs are unfit for human consumption, across the board," Baughman said. "Their side effects take two to three pages to list." .......


Would these 5 Servicemen be better off today still having their Stress, and sorting it out with friends, family and on their own, ....... or being 'Treated' for it, ...... by Ideates?

We've posted on this ongoing tragedy already. We Don't want to have to post on it again. But we are Going to, because with Govt Increasing the Funding for 'Mental Health' at Tax payer expense, ...... this IS going to keep happening in ever increasing numbers.

Our Servicemen and Servicewomen are not numbers, and they are Not disposables for Tax Funded, Change Agent, Behavioral $cientists to experiment on.

Cut the GD Funding Off, All of it. Now.

Wednesday, March 4, 2009

US Supreme Court Rules AGAINST Preemption

The SCOTUSBLOG has:

Analysis; A Warning To The FDA

There's No Need for us to sum this up. You know that We are, and have been, Against Preemption.

If you are like-minded, then Enjoy the SCOTUSBLOG's Analysis of the 6-3 decision.

Update 3/05/09: supremecourtus.gov has 80 pages for your inspection.

Monday, March 2, 2009

Non Profit Hospitals: Fraud, Abuse & Death

Op Ed News has:

Doctors Demand Justice For Patient Advocate Whistleblower
Washington- No one is safe when hospitals put profit before patients. Recent revelations of continued fraud at hospitals belonging to the chain of for-profits known as the Hospital Corporation of America (HCA, formerly known as Columbia-HCA) continue to shock the conscience of a people already reeling from fraud in the banking, mortgage and financial sectors. Will a medical meltdown be next? Public safety advocates have asked Congress to mandate special protections for medical whistleblowers. HCA has faced the largest false claims suits in history, and had paid more than $1.7 Billion dollars in fines for bilking taxpayers and patients. Despite these huge payouts, HCA apparently continues the misconduct that led to its already enormous fines. With 17% of the US GNP devoted to medical care, and with increasing amounts of bailout money going to health, the need for protection has never been greater. .......

This report details a Doctor receiving Death Threats, for exposing extensive evidence of false billing, patient endangerment, and death in Grand Jury Documents.

"Evidence shows a shocking alteration of charts, and that HCA-Virginia may actual(ly) have put patients in jeopardy in order to frame Dr. Vuyyuru."
Baltimore Sun has:

Congress Seeks To Have Hospitals Justify Their Tax-Exempt Status
"..... The Sun reported that hospital debt-collection lawsuits spiked sharply between 2003 and 2006 before falling slightly in 2007. In all, hospitals filed more than 132,000 of these suits in the past five years, winning at least $100 million in judgments and placing liens on more than 8,000 homes."
WSJ has:

Non Profit Hospitals Take Heat Over Charity At An Inopportune Time

A recent IRS report found that Under 20% of 489 Non-Profit hospitals provided 78% of the Charity care provided by the whole group. Further, the Majority, of Hospitals in the US are Non-Profits, and therefore Tax Exempt.

The IRS also determined that the average compensation, from these Non-Profit's top officials averaged a Non-Profit $490,000 a year. In 20 Large hospitals they found top execs compensation averaged $1.4 Million per year, ...... for Not making a Profit because they provide Charity Care. See Above.

also of interest:

WSJ has: (Jan 22 2009)

Pete Stark Vs Doctor Owned Hospitals

And Also under the heading of Non Profit: I.E. State Owned:

The Atlanta Journal Constitution has:

Audit Cites Flaws In Georgia's Mental System For Youths
"Last week, the state reached an agreement with the Department of Justice to make major improvements in its state psychiatric hospitals — and to spend what’s necessary to protect patients from harm. Federal investigators last year concluded that the hospitals’ failure to address critical errors caused unnecessary deaths and injuries.


The Justice Department investigation was prompted by articles in The Atlanta Journal-Constitution, which found at least 136 suspicious deaths of hospital patients and almost 200 confirmed cases of patient abuse from 2002 through late 2007."


Hmmm. For Profit And Non Profit, ...... These Hospitals are looking pretty Non Profitable to the Patient.